← Open Payments lookup

CHARLOTTE MIZUTA: Open Payments

NPI 1437791381 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$529 in 19 payments from 7 companies in 2025. Trend: 2023 $345 · 2024 $398 · 2025 $529

Food & beverage: $529
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.5$168
Alkermes, Inc.5$129
E.R. Squibb & Sons, L.L.C.3$73
Janssen Pharmaceuticals, Inc2$60
Vanda Pharmaceuticals Inc.2$56
Otsuka America Pharmaceutical, Inc.1$26
Luye Pharma (USA) Ltd.1$17

Products named: INGREZZA, ARISTADA, COBENFY, INVEGA SUSTENNA, FANAPT, ABILIFY ASIMTUFII, ERZOFRI EXTENDED-RELEASE.

Industry payments across CA — which companies pay providers there.